Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain
<p>Abstract</p> <p>Background</p> <p>The CCR2/CCL2 system has been identified as a regulator in the pathogenesis of neuropathy-induced pain. However, CCR2 target validation in analgesia and the mechanism underlying antinociception produced by CCR2 antagonists remains po...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-12-01
|
Series: | Molecular Pain |
Online Access: | http://www.molecularpain.com/content/6/1/90 |